Compare ADIL & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADIL | MGN |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.8M |
| IPO Year | 2017 | N/A |
| Metric | ADIL | MGN |
|---|---|---|
| Price | $2.58 | $0.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 12.2M |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.13 |
| 52 Week High | $5.17 | $5.18 |
| Indicator | ADIL | MGN |
|---|---|---|
| Relative Strength Index (RSI) | 54.17 | 48.33 |
| Support Level | $1.53 | $0.13 |
| Resistance Level | $2.56 | $0.20 |
| Average True Range (ATR) | 0.48 | 0.03 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 13.73 | 32.94 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.